Intended for healthcare professionals


Dutch GPs warned against new contraceptive pill

BMJ 2002; 324 doi: (Published 13 April 2002) Cite this as: BMJ 2002;324:869
  1. Tony Sheldon
  1. Utrecht

    Dutch GPs are being advised by their own professional body not to prescribe a new low dose, monophasic oral contraceptive, marketed under the trade name Yasmin, until studies have established whether it is as safe as other contraceptive pills.

    The new contraceptive, which is a combination of drospirenone (a progestogen) and ethinylestradiol, has been available in several European countries since 2000 and was approved by the US Food and Drug Administration last May. It is licensed for use in the United Kingdom, where it is being launched next week.

    Last year a 17 year old Dutch girl who had been taking Yasmin died from a …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription